注射用組換え凝固因子Ⅷのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Recombinant Coagulation Factor Ⅷ for Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16327 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

注射用組換え凝固因子Ⅷ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の注射用組換え凝固因子Ⅷの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の注射用組換え凝固因子Ⅷの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 注射用組換え凝固因子Ⅷ市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・250 IU /ボトル、500 IU /ボトル、1000 IU /ボトル、2000 IU /ボトル 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の注射用組換え凝固因子Ⅷ市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer、Novo Nordisk A/S、Baxter、Bayer、GC Pharma、Shanghai Raas Corp、Hualan Biological、Shandong Taibang Biological Products、Shanghai Xinxing Medicine、SinoCell Tech 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、注射用組換え凝固因子Ⅷ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な注射用組換え凝固因子Ⅷメーカーの企業概要、2019年～2021年までの注射用組換え凝固因子Ⅷの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な注射用組換え凝固因子Ⅷメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別注射用組換え凝固因子Ⅷの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの注射用組換え凝固因子Ⅷの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での注射用組換え凝固因子Ⅷ市場予測を収録しています。 ・第12、13、14章では、注射用組換え凝固因子Ⅷの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Novo Nordisk A/S、Baxter、Bayer、GC Pharma、Shanghai Raas Corp、Hualan Biological、Shandong Taibang Biological Products、Shanghai Xinxing Medicine、SinoCell Tech ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：250 IU /ボトル、500 IU /ボトル、1000 IU /ボトル、2000 IU /ボトル ・用途別分析2016年-2026年：病院、クリニック、その他 ・注射用組換え凝固因子Ⅷの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・注射用組換え凝固因子Ⅷのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・注射用組換え凝固因子Ⅷのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・注射用組換え凝固因子Ⅷの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・注射用組換え凝固因子Ⅷの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Recombinant Coagulation Factor Ⅷ for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Recombinant Coagulation Factor Ⅷ for Injection size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Recombinant Coagulation Factor Ⅷ for Injection market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Recombinant Coagulation Factor Ⅷ for Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
250 IU/Bottle
500 IU/Bottle
1000 IU/Bottle
2000 IU/Bottle

Market segment by Application can be divided into
Hospital
Clinic
Others

The key market players for global Recombinant Coagulation Factor Ⅷ for Injection market are listed below:
Pfizer
Novo Nordisk A/S
Baxter
Bayer
GC Pharma
Shanghai Raas Corp
Hualan Biological
Shandong Taibang Biological Products
Shanghai Xinxing Medicine
SinoCell Tech

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Recombinant Coagulation Factor Ⅷ for Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Coagulation Factor Ⅷ for Injection, with price, sales, revenue and global market share of Recombinant Coagulation Factor Ⅷ for Injection from 2019 to 2021.
Chapter 3, the Recombinant Coagulation Factor Ⅷ for Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Coagulation Factor Ⅷ for Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Recombinant Coagulation Factor Ⅷ for Injection market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Recombinant Coagulation Factor Ⅷ for Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Recombinant Coagulation Factor Ⅷ for Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 250 IU/Bottle
1.2.3 500 IU/Bottle
1.2.4 1000 IU/Bottle
1.2.5 2000 IU/Bottle
1.3 Market Analysis by Application
1.3.1 Overview: Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Coagulation Factor Ⅷ for Injection Market Size & Forecast
1.4.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales in Value (2016-2026))
1.4.2 Global Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume (2016-2026)
1.4.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2026) & (US$/Bottle)
1.5 Global Recombinant Coagulation Factor Ⅷ for Injection Production Capacity Analysis
1.5.1 Global Recombinant Coagulation Factor Ⅷ for Injection Total Production Capacity (2016-2026)
1.5.2 Global Recombinant Coagulation Factor Ⅷ for Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Recombinant Coagulation Factor Ⅷ for Injection Market Drivers
1.6.2 Recombinant Coagulation Factor Ⅷ for Injection Market Restraints
1.6.3 Recombinant Coagulation Factor Ⅷ for Injection Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.1.4 Pfizer Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novo Nordisk A/S
2.2.1 Novo Nordisk A/S Details
2.2.2 Novo Nordisk A/S Major Business
2.2.3 Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.2.4 Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.3.4 Baxter Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.4.4 Bayer Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 GC Pharma
2.5.1 GC Pharma Details
2.5.2 GC Pharma Major Business
2.5.3 GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.5.4 GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Shanghai Raas Corp
2.6.1 Shanghai Raas Corp Details
2.6.2 Shanghai Raas Corp Major Business
2.6.3 Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.6.4 Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Hualan Biological
2.7.1 Hualan Biological Details
2.7.2 Hualan Biological Major Business
2.7.3 Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.7.4 Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Shandong Taibang Biological Products
2.8.1 Shandong Taibang Biological Products Details
2.8.2 Shandong Taibang Biological Products Major Business
2.8.3 Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.8.4 Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Shanghai Xinxing Medicine
2.9.1 Shanghai Xinxing Medicine Details
2.9.2 Shanghai Xinxing Medicine Major Business
2.9.3 Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.9.4 Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 SinoCell Tech
2.10.1 SinoCell Tech Details
2.10.2 SinoCell Tech Major Business
2.10.3 SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Product and Services
2.10.4 SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Recombinant Coagulation Factor Ⅷ for Injection Sales by Manufacturer
3.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Recombinant Coagulation Factor Ⅷ for Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Recombinant Coagulation Factor Ⅷ for Injection Manufacturer Market Share
3.4.2 Top 6 Recombinant Coagulation Factor Ⅷ for Injection Manufacturer Market Share
3.5 Global Recombinant Coagulation Factor Ⅷ for Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Recombinant Coagulation Factor Ⅷ for Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region
4.1.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2026)
4.2 North America Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026)
4.3 Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026)
4.4 Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026)
4.5 South America Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026)
4.6 Middle East and Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Type (2016-2026)
5.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2026)
5.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Application (2016-2026)
6.2 Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2026)
6.3 Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2026)
7.2 North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2026)
7.3 North America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
7.3.1 North America Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2026)
8.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2026)
8.3 Europe Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
8.3.1 Europe Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Market Size by Region
9.3.1 Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2026)
10.2 South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2026)
10.3 South America Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
10.3.1 South America Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Market Size by Country
11.3.1 Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Recombinant Coagulation Factor Ⅷ for Injection Typical Distributors
12.3 Recombinant Coagulation Factor Ⅷ for Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 6. Pfizer Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk A/S Major Business
Table 9. Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 10. Novo Nordisk A/S Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Baxter Basic Information, Manufacturing Base and Competitors
Table 12. Baxter Major Business
Table 13. Baxter Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 14. Baxter Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 18. Bayer Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 20. GC Pharma Major Business
Table 21. GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 22. GC Pharma Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Shanghai Raas Corp Basic Information, Manufacturing Base and Competitors
Table 24. Shanghai Raas Corp Major Business
Table 25. Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 26. Shanghai Raas Corp Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 28. Hualan Biological Major Business
Table 29. Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 30. Hualan Biological Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Shandong Taibang Biological Products Basic Information, Manufacturing Base and Competitors
Table 32. Shandong Taibang Biological Products Major Business
Table 33. Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 34. Shandong Taibang Biological Products Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Shanghai Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 36. Shanghai Xinxing Medicine Major Business
Table 37. Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 38. Shanghai Xinxing Medicine Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. SinoCell Tech Basic Information, Manufacturing Base and Competitors
Table 40. SinoCell Tech Major Business
Table 41. SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Product and Services
Table 42. SinoCell Tech Recombinant Coagulation Factor Ⅷ for Injection Sales (K Bottle), Price (US$/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Manufacturer (2019-2021e) & (K Bottle)
Table 44. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Recombinant Coagulation Factor Ⅷ for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Recombinant Coagulation Factor Ⅷ for Injection Production Capacity by Company, (K Bottle): 2020 VS 2021
Table 47. Head Office and Recombinant Coagulation Factor Ⅷ for Injection Production Site of Key Manufacturer
Table 48. Recombinant Coagulation Factor Ⅷ for Injection New Entrant and Capacity Expansion Plans
Table 49. Recombinant Coagulation Factor Ⅷ for Injection Mergers & Acquisitions in the Past Five Years
Table 50. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2016-2021e) & (K Bottle)
Table 51. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2021-2026) & (K Bottle)
Table 52. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021e) & (K Bottle)
Table 55. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2021-2026) & (K Bottle)
Table 56. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2021e) & (US$/Bottle)
Table 59. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2021-2026) & (US$/Bottle)
Table 60. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021e) & (K Bottle)
Table 61. Global Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2021-2026) & (K Bottle)
Table 62. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2016-2021e) & (US$/Bottle)
Table 65. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2021-2026) & (US$/Bottle)
Table 66. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021e) & (K Bottle)
Table 67. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2021-2026) & (K Bottle)
Table 68. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021e) & (K Bottle)
Table 71. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2021-2026) & (K Bottle)
Table 72. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021e) & (K Bottle)
Table 73. North America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2021-2026) & (K Bottle)
Table 74. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021e) & (K Bottle)
Table 75. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2021-2026) & (K Bottle)
Table 76. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021e) & (K Bottle)
Table 79. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2021-2026) & (K Bottle)
Table 80. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021e) & (K Bottle)
Table 81. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2021-2026) & (K Bottle)
Table 82. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2016-2021e) & (K Bottle)
Table 83. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Region (2021-2026) & (K Bottle)
Table 84. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021e) & (K Bottle)
Table 87. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2021-2026) & (K Bottle)
Table 88. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021e) & (K Bottle)
Table 89. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2021-2026) & (K Bottle)
Table 90. South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021e) & (K Bottle)
Table 91. South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2021-2026) & (K Bottle)
Table 92. South America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021e) & (K Bottle)
Table 95. South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2021-2026) & (K Bottle)
Table 96. South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021e) & (K Bottle)
Table 97. South America Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2021-2026) & (K Bottle)
Table 98. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2016-2021e) & (K Bottle)
Table 99. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Country (2021-2026) & (K Bottle)
Table 100. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2016-2021e) & (K Bottle)
Table 103. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Type (2021-2026) & (K Bottle)
Table 104. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2016-2021e) & (K Bottle)
Table 105. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales by Application (2021-2026) & (K Bottle)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Recombinant Coagulation Factor Ⅷ for Injection Typical Distributors
Table 109. Recombinant Coagulation Factor Ⅷ for Injection Typical Customers
List of Figures
Figure 1. Recombinant Coagulation Factor Ⅷ for Injection Picture
Figure 2. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type in 2020
Figure 3. 250 IU/Bottle
Figure 4. 500 IU/Bottle
Figure 5. 1000 IU/Bottle
Figure 6. 2000 IU/Bottle
Figure 7. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size, (USD Million) & (K Bottle): 2020 VS 2021 VS 2026
Figure 12. Global Recombinant Coagulation Factor Ⅷ for Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Recombinant Coagulation Factor Ⅷ for Injection Sales (2016-2026) & (K Bottle)
Figure 14. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2026) & (US$/Bottle)
Figure 15. Global Recombinant Coagulation Factor Ⅷ for Injection Production Capacity (2016-2026) & (K Bottle)
Figure 16. Global Recombinant Coagulation Factor Ⅷ for Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Recombinant Coagulation Factor Ⅷ for Injection Market Drivers
Figure 18. Recombinant Coagulation Factor Ⅷ for Injection Market Restraints
Figure 19. Recombinant Coagulation Factor Ⅷ for Injection Market Trends
Figure 20. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Manufacturer in 2020
Figure 21. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Manufacturer in 2020
Figure 22. Recombinant Coagulation Factor Ⅷ for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Recombinant Coagulation Factor Ⅷ for Injection Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Recombinant Coagulation Factor Ⅷ for Injection Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2016-2026)
Figure 26. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2016-2026)
Figure 27. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026) & (USD Million)
Figure 28. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026) & (USD Million)
Figure 30. South America Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue (2016-2026) & (USD Million)
Figure 32. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2026)
Figure 33. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Type (2016-2026)
Figure 34. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Type (2016-2026) & (US$/Bottle)
Figure 35. Global Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2026)
Figure 36. Global Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Application (2016-2026)
Figure 37. Global Recombinant Coagulation Factor Ⅷ for Injection Price by Application (2016-2026) & (US$/Bottle)
Figure 38. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2026)
Figure 39. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2026)
Figure 40. North America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2016-2026)
Figure 41. North America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2016-2026)
Figure 42. United States Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2026)
Figure 46. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2026)
Figure 47. Europe Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2016-2026)
Figure 48. Europe Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2016-2026)
Figure 49. Germany Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Region (2016-2026)
Figure 58. China Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2026)
Figure 65. South America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2026)
Figure 66. South America Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2016-2026)
Figure 67. South America Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Recombinant Coagulation Factor Ⅷ for Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source

---